Editorial to the Special Issue “Activations of Cadherin Signaling in Cancer” by Antonella Tomassetti

Get full text

Impairment of RAD17 Functions by miR-506-3p as a Novel Synthetic Lethal Approach Targeting DNA Repair Pathways in Ovarian Cancer by Marina Bagnoli, Roberta Nicoletti, Monica Valitutti, Andrea Rizzo, Alessandra Napoli, Rafaela Montalvão De Azevedo, Antonella Tomassetti, Delia Mezzanzanica

Get full text

A Cell-Autonomous Oncosuppressive Role of Human RNASET2 Affecting ECM-Mediated Oncogenic Signaling by Francesca Roggiani, Cristina Riva, Francesco Raspagliesi, Giovanni Porta, Roberto Valli, Roberto Taramelli, Francesco Acquati, Delia Mezzanzanica, Antonella Tomassetti

Get full text

Variant HNF1 Modulates Epithelial Plasticity of Normal and Transformed Ovary Cells by Antonella Tomassetti, Giuseppina De Santis, Giancarlo Castellano, Silvia Miotti, Mimma Mazzi, Daniela Tomasoni, Frans Van Roy, Maria Luisa Carcangiu, Silvana Canevari

Get full text

Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomas. by Debora Degl'Innocenti, Chiara Alberti, Giancarlo Castellano, Angela Greco, Claudia Miranda, Marco A Pierotti, Ettore Seregni, Maria Grazia Borrello, Silvana Canevari, Antonella Tomassetti

Get full text

Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells by Andrea Rizzo, Alessandro Satta, Giulia Garrone, Adalberto Cavalleri, Alessandra Napoli, Francesco Raspagliesi, Mariangela Figini, Loris De Cecco, Egidio Iorio, Antonella Tomassetti, Delia Mezzanzanica, Marina Bagnoli

Get full text

Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth by Katia Rea, Francesca Roggiani, Loris De Cecco, Francesco Raspagliesi, Maria Luisa Carcangiu, Joyce Nair-Menon, Marina Bagnoli, Ileana Bortolomai, Delia Mezzanzanica, Silvana Canevari, Antonis Kourtidis, Panos Z. Anastasiadis, Antonella Tomassetti

Get full text

Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial by Luca Forlani, Loris De Cecco, Vittorio Simeon, Biagio Paolini, Marina Bagnoli, Sabrina Chiara Cecere, Anna Spina, Eleonora Citeroni, Eliana Bignotti, Domenica Lorusso, Laura Arenare, Daniela Russo, Carmine De Angelis, Laura Ardighieri, Giosuè Scognamiglio, Michele Del Sesto, Germana Tognon, Daniela Califano, Clorinda Schettino, Paolo Chiodini, Francesco Perrone, Delia Mezzanzanica, Sandro Pignata, Antonella Tomassetti

Get full text